| Literature DB >> 26195510 |
Xiuyun Li1, Yinglong Hou2, Longtao Yue3, Shuyuan Liu1, Juan Du3, Shujuan Sun4.
Abstract
Fungal infections, especially infections caused by Candida albicans, remain a challenging problem in clinical settings. Despite the development of more-effective antifungal drugs, their application is limited for various reasons. Thus, alternative treatments with drugs aimed at novel targets in C. albicans are needed. Knowledge of growth and virulence in fungal cells is essential not only to understand their pathogenic mechanisms but also to identify potential antifungal targets. This article reviews the current knowledge of the mechanisms of growth and virulence in C. albicans and examines potential targets for the development of new antifungal drugs.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26195510 PMCID: PMC4576120 DOI: 10.1128/AAC.00726-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191